Published in Clin J Am Soc Nephrol on February 16, 2016
Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med (1996) 4.41
Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol (2003) 2.27
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol (2005) 2.25
Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2010) 2.24
Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis (1998) 1.63
Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study. Nephron Clin Pract (2006) 1.63
Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis (1995) 1.61
Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Nephrol Dial Transplant (2007) 1.55
Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol (1990) 1.16
Treatment of primary focal segmental glomerulosclerosis. Kidney Int (2002) 1.06
Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04
Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med (1987) 1.04
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM (2005) 0.96
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant (2004) 0.96
Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic. Clin Nephrol (2001) 0.86
The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine (Baltimore) (1986) 0.85
The treatment of idiopathic focal segmental glomerulosclerosis in adults. Adv Chronic Kidney Dis (2014) 0.81
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol (2016) 0.81
Antihypertensive Medication in Patients Pre- and Postdialysis: Still Hazy After All These Years. Clin J Am Soc Nephrol (2016) 0.75